Skip to search formSkip to main contentSkip to account menu
You are currently offline. Some features of the site may not work correctly.

Sch 42427

Known as: Sch-42427 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
The topical antifungal Sch-39304 is a racemic compound comprised of two enantiomers, Sch-42427 and Sch-42426, only one of which… 
2002
2002
Genaconazole (SCH 39304) is a potent triazole antifungal agent that is active both orally and topically. Genaconazole is a… 
1995
1995
A series of azole derivatives carrying an N-acylmorpholine ring are described. The compounds were chemically designed to simulate… 
1993
1993
Paracoccidioidomycosis is characterized by depressed cellular but enhanced humoral immune responses, which suggests a Th2 type of… 
Highly Cited
1992
Highly Cited
1992
Concentrations of oral azoles in serum were compared in a single-dose pharmacologic study in mice. When hydroxypropyl-beta… 
1992
1992
SCH 39304, a new triazole antifungal agent, is a 50:50 racemic mixture of two enantiomers, SCH 42427 and SCH 42426. The… 
Review
1992
Review
1992
Disseminated candidiasis is the most common life-threatening invasive fungal infection in granulocytopenic patients. A review of… 
1992
1992
SCH 39304 (304) and its isomers, SCH 42426 (426) and SCH 42427 (427), are new orally administered antifungal azole derivatives…